The Australian Treatment Outcome Study (ATOS): What have we learnt about treatment for heroin dependence?

Drug and Alcohol Review

Volumn 26, Issue 1, 2007, Pages 49-54

  Darke, Shane ^a   Ross, Joanne ^a   Teesson, Maree ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cohort; Heroin; Outcome; Treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT;

AUSTRALIA; COHORT ANALYSIS; COMORBIDITY; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL PROBLEM; TREATMENT OUTCOME;

AUSTRALIA; BUPRENORPHINE; COHORT STUDIES; COMORBIDITY; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; METHADONE; NARCOTICS; SOCIAL PROBLEMS; TREATMENT OUTCOME;

EID: 33847231310     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230601036986     Document Type: Review

References (31)

1. Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users: epidemiology, causes and intervention, Cambridge: Cambridge University Press, 2007.
2. Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study. Addict Behav 2002;27:155-66.
3. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psych Addict Behav 1997;11:261-78.
4. Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005;24:411-8.
5. Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005;78:309-15.
6. Mills K, Teesson M, Lynskey M, Ross J, Darke S. Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2004;27:67-73.
7. Grant BF, Dawson DA. Age of onset and its association with DSM-IV drug abuse and dependence: results form the National Longitudinal Alcohol Epidemiological Survey. J Substance Abuse 1998;10:163-73.
8. Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004;23:177-83.
9. Darke S, Ross J, Teesson M. Twelve month outcomes for heroin dependence treatments: does route of administration matter? Drug Alcohol Rev 2005;24:165-71.
10. Darke S, Williamson A, Ross J, Teesson M. Residential rehabilitation for the treatment of heroin dependence: sustained heroin abstinence and drug-related problems two years after treatment entrance. Addict Disorders Treat 2006;5:9-18.
11. Ross J, Teesson M, Darke S, et al. Short-term outcomes for the treatment of heroin dependence: findings from Australian Treatment Outcome Study (ATOS). Addict Disorders Treat 2006;5:133-44.
12. Teesson M, Havard A, Ross J, Darke S. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006;25:241-7.
13. Teesson M, Ross J, Darke S, et al. The Australian Treatment Outcome Study (ATOS): 1 year follow-up results. Drug Alcohol Depend 2006;83:174-80.
14. Darke S, Ross J, Teesson M, et al. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2005;28:255-63.
15. Darke S, Williamson A, Ross J, Teesson M. Heroin overdose, treatment exposure and client characteristics: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005;24:425-32.
16. Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction 2001;96:1113-25.
17. Darke S, Williamson A, Ross J, Teesson M. Reductions in heroin use are not associated with increases in other drug use: two year findings from the Australian Treatment Outcome Study. Drug Alcohol Depend 2006;84:201-5.
18. Darke S, Ross J, Teesson M, Lynskey M. Health service utilisation and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003;98:1129-35.
19. Darke S, Havard A, Ross J, Mills K, Teesson M. Changes in the use of medical services and prescription drugs amongst heroin users over two years. Drug Alcohol Rev, in press.
20. Williamson A, Darke S, Ross J, Teesson M. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006;25:139-46.
21. Williamson A, Darke S, Ross J, Teesson M. The effects of persistence of cocaine use on 12 month outcomes for the treatment of heroin dependence. Drug Alcohol Depend 2006;81:293-300.
22. Darke S, Ross J, Teesson M, Lynskey M. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Drug Alcohol Depend 2004;73:1-10.
23. Darke S, Williamson A, Ross J, Teesson M. Attempted suicide among heroin users: 12 month outcomes form the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2005;78:177-86.
24. Havard A, Teesson M, Darke S, Ross J. Depression among heroin users: 12 month outcomes from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2006;30:355-62.
25. Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Posttraumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug Alcohol Depend 2005;77:243-9.
26. Mills KL, Teesson M, Ross J, Darke S, Shanahan MA. The costs and outcomes of treatment for opioid dependence associated with Posttraumatic Stress Disorder. Psych Services 2005;56:940-5.
27. Najavits LM. Seeking safety: a treatment manual for PTSD and substance abuse. New York: Guilford Press, 2002.
28. Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004;74:77-83.
29. Darke S, Ross J, Williamson A, Teesson M. The impact of Borderline Personality Disorder on 12 month outcomes for the treatment of heroin dependence. Addiction 2005;100:1121-30.
30. Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003;356:959-60.
31. Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering 'route transition interventions'. Drug Alcohol Rev 1999;18:441-5.